AltPep

Alt Pep

Biotechnology, 100 Ne Northlake Way Ste 300, Seattle, Washington, 98105, United States, 11-50 Employees

altpep.com

  • LinkedIn

phone no Phone Number: 42********

Who is ALTPEP

AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers toxic soluble oligomers. These oligomers ar...

Read More

map
  • 100 Ne Northlake Way Ste 300, Seattle, Washington, 98105, United States Headquarters: 100 Ne Northlake Way Ste 300, Seattle, Washington, 98105, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 1731

checked-icon Does something look wrong? Fix it. | View contact records from ALTPEP

AltPep Org Chart and Mapping

Employees

Milo Ryan

Research Associate III

Yan Chan

Medical Lab Scientist

Kurt Becker

Vice President, Legal and Business Development

Jae Park

Director of Drug Discovery Development

Julia Loghinov

Laboratory Research Assistant

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding AltPep

Answer: AltPep's headquarters are located at 100 Ne Northlake Way Ste 300, Seattle, Washington, 98105, United States

Answer: AltPep's phone number is 42********

Answer: AltPep's official website is https://altpep.com

Answer: AltPep's revenue is $1 Million to $5 Million

Answer: AltPep's SIC: 1731

Answer: AltPep has 11-50 employees

Answer: AltPep is in Biotechnology

Answer: AltPep contact info: Phone number: 42******** Website: https://altpep.com

Answer: AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach. Our lead program aims to identify Alzheimers Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access